Status: Recruiting
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
This study is being conducted to study how nirogacestat may affect the ovarian function of adult premenopausal women with progressing desmoid tumors/aggressive fibromatosis.
Participants needed: 50
Trial details
Phase: Phase 4Age: 18-40Biological sex: FemaleType: InterventionalSponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyUpdated: Jun 22, 2026Locations: 23
Eligibility criteria
Participant is female, postpubertal aged ≥18 and ≤40 years of age at the time of... [+4]
Participant has known malabsorption syndrome or preexisting gastrointestinal con... [+11]